0000950170-24-064843.txt : 20240524
0000950170-24-064843.hdr.sgml : 20240524
20240524194847
ACCESSION NUMBER: 0000950170-24-064843
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Atkins Michael B.
CENTRAL INDEX KEY: 0002004793
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40366
FILM NUMBER: 24985996
MAIL ADDRESS:
STREET 1: C/O WEREWOLF THERAPEUTICS, INC.
STREET 2: 200 TALCOTT AVE., 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Werewolf Therapeutics, Inc.
CENTRAL INDEX KEY: 0001785530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 823523180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-952-0555
MAIL ADDRESS:
STREET 1: 200 TALCOTT AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
ownership.xml
4
X0508
4
2024-05-24
0001785530
Werewolf Therapeutics, Inc.
HOWL
0002004793
Atkins Michael B.
C/O WEREWOLF THERAPEUTICS, INC.
200 TALCOTT AVENUE, 2ND FLOOR
WATERTOWN
MA
02472
true
false
false
false
false
Stock Option (right to buy)
4.88
2024-05-24
4
A
false
6723
0.00
A
2034-05-23
Common Stock
6723
6723
D
The option was granted on May 24, 2024. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.
/s/ Jonathan Owen, Attorney-in-fact
2024-05-24